Page last updated: 2024-09-04

atrasentan and Fibrosis

atrasentan has been researched along with Fibrosis in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's5 (62.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Aubert, JD; Juillerat-Jeanneret, L1
Baelde, HJ; Bajema, IM; Bos, M; Bruijn, JA; Dijkstra, KL; van Aanhold, CCL; van den Berg, BM; Wolterbeek, R1
Lin, L; Liu, Y; Tan, RJ; Zhou, D; Zhou, L1
Chang, NC; Chung, TH; Lee, TM; Lin, SZ1
Liu, KD1
Chen, CC; Hsu, YJ; Lee, TM1
Brunner, F; Kirchengast, M; Pang, X; Stessel, H; Wölkart, G1
Ammarguellat, F; Larouche, I; Schiffrin, EL1

Reviews

2 review(s) available for atrasentan and Fibrosis

ArticleYear
Endothelin-Receptor Antagonists beyond Pulmonary Arterial Hypertension: Cancer and Fibrosis.
    Journal of medicinal chemistry, 2016, 09-22, Volume: 59, Issue:18

    Topics: Animals; Cardiovascular Diseases; Clinical Trials as Topic; Endothelin Receptor Antagonists; Fibrosis; Humans; Hypertension, Pulmonary; Neoplasms; Receptors, Endothelin

2016
Therapeutic strategies for clinical trials targeting renal recovery.
    Nephron. Clinical practice, 2014, Volume: 127, Issue:1-4

    Topics: Acute Kidney Injury; Animals; Atrasentan; Biomarkers; Caloric Restriction; Clinical Trials as Topic; Disease Models, Animal; Fibrosis; Follow-Up Studies; Humans; Inflammation; Kidney; Kidney Function Tests; Mesenchymal Stem Cell Transplantation; Meta-Analysis as Topic; Pyrrolidines; Recovery of Function; Regeneration; Renal Insufficiency, Chronic; Renal Replacement Therapy; Respiratory Distress Syndrome; Risk Factors; Treatment Outcome

2014

Other Studies

6 other study(ies) available for atrasentan and Fibrosis

ArticleYear
Reduced Glomerular Endothelial Thrombomodulin Is Associated with Glomerular Macrophage Infiltration in Diabetic Nephropathy.
    The American journal of pathology, 2021, Volume: 191, Issue:5

    Topics: Animals; Atrasentan; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Endothelin A Receptor Antagonists; Endothelium; Fibrosis; Humans; Inflammation; Kidney; Kidney Glomerulus; Macrophages; Male; Mice; Mice, Knockout; Thrombomodulin

2021
Endothelin receptor a blockade is an ineffective treatment for adriamycin nephropathy.
    PloS one, 2013, Volume: 8, Issue:11

    Topics: Animals; Atrasentan; Disease Models, Animal; Doxorubicin; Endothelin A Receptor Antagonists; Fibrosis; Gene Expression; Kidney Diseases; Kidney Glomerulus; Male; Mice; Podocytes; Proteinuria; Pyrrolidines; Receptor, Endothelin A

2013
Endothelin receptor blockade ameliorates renal injury by inhibition of RhoA/Rho-kinase signalling in deoxycorticosterone acetate-salt hypertensive rats.
    Journal of hypertension, 2014, Volume: 32, Issue:4

    Topics: Animals; Atrasentan; Blood Pressure; Desoxycorticosterone Acetate; Endothelin Receptor Antagonists; Endothelin-1; Fibrosis; Gene Expression Regulation; Hypertension; Kidney; Male; Proteinuria; Pyrrolidines; Random Allocation; Rats; Rats, Wistar; rho-Associated Kinases; rhoA GTP-Binding Protein; Sodium Chloride, Dietary

2014
Impact of elevated uric acid on ventricular remodeling in infarcted rats with experimental hyperuricemia.
    American journal of physiology. Heart and circulatory physiology, 2011, Volume: 301, Issue:3

    Topics: Allopurinol; Analysis of Variance; Animals; Antioxidants; Atrasentan; Biomarkers; Cyclic N-Oxides; Dinoprost; Disease Models, Animal; Endothelin A Receptor Antagonists; Endothelin-1; Fibrosis; Gout Suppressants; Hypertrophy, Left Ventricular; Hyperuricemia; Isoprostanes; Male; Myocardial Infarction; Myocardium; Oxidative Stress; Pyrrolidines; Rats; Rats, Wistar; Receptor, Endothelin A; RNA, Messenger; Spin Labels; Superoxides; Time Factors; Up-Regulation; Uric Acid; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling; Xanthine Oxidase

2011
Chronic endothelin-A receptor antagonism is as protective as angiotensin converting enzyme inhibition against cardiac dysfunction in diabetic rats.
    British journal of pharmacology, 2007, Volume: 151, Issue:8

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atrasentan; Cardiovascular Diseases; Diabetes Mellitus, Experimental; Endothelin A Receptor Antagonists; Female; Fibrosis; Myocardial Reperfusion Injury; Nitric Oxide Synthase; Oxidative Stress; Pyrrolidines; Ramipril; Rats; Rats, Sprague-Dawley; Streptozocin; Ventricular Function, Left; Ventricular Pressure

2007
Myocardial fibrosis in DOCA-salt hypertensive rats: effect of endothelin ET(A) receptor antagonism.
    Circulation, 2001, Jan-16, Volume: 103, Issue:2

    Topics: Animals; Atrasentan; Blood Pressure; Collagen; Collagen Type I; Desoxycorticosterone; Endothelin A Receptor Antagonists; Fibrosis; Hypertension; Male; Myocardium; Organ Size; Pyrrolidines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sodium Chloride; Transforming Growth Factor beta; Transforming Growth Factor beta1

2001